More NewsRead More
Emisphere to Present at SeeThruEquity MicroCap Investor Forum
November 05, 2015
Emisphere Signs License Agreement With Novo Nordisk to Develop Oral Formulations of Four Molecules Targeting Metabolic Indications and Amends GLP-1 Agreement
October 15, 2015
Emisphere to Present at Rodman and Renshaw 17th Annual Global Investment Conference
September 02, 2015
Emisphere Highlights Eligen Licensee Novo Nordisk's Entry Into Phase 3a Development of Oral Semaglutide, a Once Daily Oral GLP-1
August 26, 2015
Emisphere Reports Second Quarter 2015 Financial Results
August 12, 2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here